A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy.

Fahey, Michael (Primary Chief Investigator (PCI))

Paediatrics Monash Health

Project: Research

Project Description

ERM Project ID: 87196
Monash Health Reference: RES-23-0000-104A

Status	Active
Effective start/end date	30/08/23 → 29/08/28

Clinical Trial Phase

Phase III (a & b)